Monod Bio, Inc. reported raising $24.2 Million in an initial SEC Form D filing, from an offering of $26.3 Million
Amount Raised
$24.2 Million
Round Type
Venture
SeattleBiotechnologyQuick answer
Monod Bio, Inc. raised $24.2 Million in a funding round, dated June 24, 2022. Monod Bio, Inc. is based in Seattle, Washington, United States.
- How much did Monod Bio, Inc. raise?
- Monod Bio, Inc. raised $24.2 Million in a funding round on June 24, 2022.
- What does Monod Bio, Inc. do?
- Monod Bio l Simple. Powerful.
- Where is Monod Bio, Inc. based and how big is it?
- Monod Bio, Inc. is based in Seattle, Washington, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Monod Bio, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Innervace raised $10M on August 8, 2022.
- Avinger Inc raised $2.4M (Seed) on August 8, 2022.
- Eyestem raised an undisclosed amount (Funding Round) on August 8, 2022.
- Nortis Inc raised $6M on August 8, 2022.
- Skylark Bio raised $23M on August 8, 2022.
- Epigenic Therapeutics raised $20M (Series A) on August 6, 2022.
Who to call at Monod Bio, Inc., and when
A new round usually means Monod Bio, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Monod Bio, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Monod Bio, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Monod Bio, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Monod Bio, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Monod Bio, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.